Clinical effect of regional citrate anticoagulation continuous renal replacement therapy in three patients with hypercalcemic crisis

Abstract

In this study, we investigated the effectiveness of regional citrate anticoagulation continuous renal replacement therapy (RCA-CRRT) in reducing blood calcium levels in three patients with hypercalcemia crisis caused by different etiologies. The sodium citrate chelation of calcium ions was utilized as an anticoagulant for treating severely affected patients. By adjusting the citrate anticoagulant dose and monitoring treatment indicators, RCA-CRRT parameters were actively modified to alleviate the hypercalcemia crisis and provide time for surgery or specialized treatment. Two patients experienced rapid and effective reductions in blood calcium levels, allowing for further treatment, while the third patient exhibited a repeated increase in blood calcium, which eventually decreased after parathyroid adenoma resection, leading to clinical discharge. Our findings suggest that RCA-CRRT can help alleviate hypercalcemia crisis, stabilize the patient’s internal environment, and provide valuable time for clinical treatment in cases of various medical conditions causing abnormal blood calcium elevations.

Keywords

Hypercalcium crisis RCA-CRRT blood calcium hemodialysis renal replacement therapy

Get full access to this article

View all access options for this article.

References

Ning

Meng

Zhu

Application of local citrate anticoagulant in continuous renal replacement therapy for patients with hepatic failure. Chin J Liver Dis 2018; 26(7): 549–552.

Zhou

, et al. Application of improved sodium citrate infusion method in continuous blood purification patients. Chin J Nurs 2020; 55(12): 1850–1854.

Fan

Tian

Zhou

Localization and diagnosis of primary hyperparathyroidism. Chin J Osteoporosis 2018; 2: 215–219.

Xie

, et al. Research progress in the pathogenesis and target therapy of multiple myeloma bone disease. Chin J Hematol 2011; 33(3): 247–249.

Zhang

Deng

Guo

, et al. Hypercalcium crisis after primary hyperparathyroidism: a case report. Chin J Endocrinol Surg 2020; 14(4): 347–349.

Fotiou

Dimopoulos

Kastritis

Managing renal complications in multiple myeloma. J Expert Rev Hematol 2016; 9(9): 839–850.

Jiang

Zhang

Jin

, et al. Research progress of citric acid for calcium ion management in local anticoagulation of CRRT. Chin J Hematol 2019; 18(8): 553–555.

Wang

Yang

, et al. Citrate anticoagulation hemofiltration in the treatment of hypercalcemia should slow the loss of calcium. J Blood Purifi China 2018; 2: 144.

Cui

Good covering on the curative effect of chronic kidney disease mineral and bone abnormalities observed. J Chin Blood Purifi 2016; 15(3): 154–158.

10.

Barstow

Electrolytes: calcium disorders. FP Essent 2017; 459: 29–34.

11.

Wang

Gao

, et al. Study on initial anticoagulant dose of sodium citrate after continuous veno-venous hemofiltration. Chinas Emerg Med 2020; 40(2): 137–141.

12.

Chen

Standard operating procedures for blood purification. 2020 ed. Beijing: People’s Military Medical Press, 2020, pp.149–154.

13.

Hetzel

Taskaya

Sucker

, et al. Citrate plasma levels in patients under regional anticoagulation in continuous venovenous hemofiltration. Am J Kidney Dis 2006; 13(5): 806–811.

14.

Kasperk C. Hypercalcemic crisis and hypocalcemictetany. Int J Crisis Manage 2017; 58(10): 1029–1036.

15.

Caliskan

Kizilgul

Beysel

, et al. Factors associated with glomerular filtration rate variation in primary hyperparathyroidism after mectomyectomy. Turk J Med Sci 2019; 49(1): 295–300.